Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia

Purinergic Signalling

Volumn 7, Issue 4, 2011, Pages 427-434

  Sun, Xiaofeng ^a   Imai, Masato ^a   Nowak Machen, Martina ^a,b   Guckelberger, Olaf ^c   Enjyoji, Keiichi ^a   Wu, Yan ^a   Khalpey, Zain ^b   Berberat, Pascal ^a   Munasinghe, Jeeva ^d   Robson, Simon Christopher ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

CD39; Hepatic ischemia reperfusion; Vascular endothelium

Indexed keywords

EID: 81955160849     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-011-9239-6     Document Type: Article

References (39)

1. Thiagarajan RR, Winn RK, Harlan JM (1997) The role of leukocyte and endothelial adhesion molecules in ischemia-reperfusion injury. Thromb Haemost 78: 310-314.
2. Milazzo VJ, Ferrante RJ, Sabido F et al (1996) Time course of leukocyte adhesion to endothelium in ischemia-reperfusion. J Surg Res 61: 139-142.
3. Squadrito F, Altavilla D, Squadrito G et al (1997) The involvement of tumour necrosis factor-alpha in the protective effects of 17 beta oestradiol in splanchnic ischaemia-reperfusion injury. Br J Pharmacol 121: 1782-1788.
4. Rose S, Floyd RA, Eneff K et al (1994) Intestinal ischemia: reperfusion-mediated increase in hydroxyl free radical formation as reported by salicylate hydroxylation. Shock 1: 452-456.
5. Kaczmarek E, Erb L, Koziak K et al (2005) Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways. Thromb Haemost 93: 735-742.
6. Marcus AJ, Broekman MJ, Drosopoulos JH et al (1997) The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 99: 1351-1360.
7. Corriden R, Chen Y, Inoue Y et al (2008) Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine. J Biol Chem 283: 28480-28486.
8. Body SC (1996) Platelet activation and interactions with the microvasculature. J Cardiovasc Pharmacol 27(Suppl 1): S13-S25.
9. Goepfert C, Imai M, Brouard S et al (2000) CD39 modulates endothelial cell activation and apoptosis. Mol Med 6: 591-603.
10. Candinas D, Koyamada N, Miyatake T et al (1996) Loss of rat glomerular ATP diphosphohydrolase activity during reperfusion injury is associated with oxidative stress reactions. Thromb Haemost 76: 807-812.
11. Enjyoji K, Sevigny J, Lin Y et al (1999) Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5: 1010-1017.
12. Enjyoji K, Kotani K, Thukral C et al (2008) Deletion of cd39/entpd1 results in hepatic insulin resistance. Diabetes 57: 2311-2320.
13. Mizumoto N, Kumamoto T, Robson SC et al (2002) CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 8: 358-365.
14. Deaglio S, Dwyer KM, Gao W et al (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204: 1257-1265.
15. Smedsrod B, De Bleser PJ, Braet F et al (1994) Cell biology of liver endothelial and Kupffer cells. Gut 35: 1509-1516.
16. Beldi G, Wu Y, Banz Y et al (2008) Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Hepatology 48: 841-852.
17. Dranoff JA, Kruglov EA, Robson SC et al (2002) The ecto-nucleoside triphosphate diphosphohydrolase NTPDase2/CD39L1 is expressed in a novel functional compartment within the liver. Hepatology 36: 1135-1144.
18. Beldi G, Wu Y, Sun X et al (2008) Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration. Gastroenterology 135(5): 1751-1760.
19. Imai M, Takigami K, Guckelberger O et al (1999) Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection. Mol Med 5: 743-752.
20. Yadav SS, Gao W, Harland RC, Clavien PA (1998) A new and simple technique of total hepatic ischemia in the mouse. Transplantation 65: 1433-1436.
21. Dufour DR, Lott JA, Nolte FS et al (2000) Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 46: 2050-2068.
22. Hallahan DE, Staba-Hogan MJ, Virudachalam S, Kolchinsky A (1998) X-ray-induced P-selectin localization to the lumen of tumor blood vessels. Cancer Res 58: 5216-5220.
23. Colpaert CG, Vermeulen PB, Benoy I et al (2003) Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression. Br J Cancer 88: 718-725.
24. Grenz A, Zhang H, Hermes M et al (2007) Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury. FASEB J 21: 2863-2873.
25. Kohler D, Eckle T, Faigle M et al (2007) CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 116: 1784-1794.
26. Pinsky DJ, Yan SF, Lawson C et al (1995) Hypoxia and modification of the endothelium: implications for regulation of vascular homeostatic properties. Semin Cell Biol 6: 283-294.
27. Dwyer KM, Robson SC, Nandurkar HH et al (2004) Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 113: 1440-1446.
28. Guckelberger O, Sun XF, Sevigny J et al (2004) Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury. Thromb Haemost 91: 576-586.
29. Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117: 175-184.
30. Dwyer KM, Deaglio S, Gao W et al (2007) CD39 and control of cellular immune responses. Purinergic Signal 3: 171-180.
31. Hyman MC, Petrovic-Djergovic D, Visovatti SH et al (2009) Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J Clin Invest 119: 1136-1149.
32. Pinsky DJ, Broekman MJ, Peschon JJ et al (2002) Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest 109: 1031-1040.
33. Day YJ, Marshall MA, Huang L et al (2004) Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am J Physiol Gastrointest Liver Physiol 286: G285-G293.
34. Day YJ, Li Y, Rieger JM et al (2005) A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury. J Immunol 174: 5040-5046.
35. Lappas CM, Day YJ, Marshall MA et al (2006) Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med 203: 2639-2648.
36. Linden J (2001) Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41: 775-787.
37. Yu L, Huang Z, Mariani J et al (2004) Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury. Nat Med 10: 1081-1087.
38. Sitkovsky MV, Lukashev D, Apasov S et al (2004) Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 22: 657-682.
39. Friedman DJ, Rennke HG, Csizmadia E et al (2007) The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy. Diabetes 56: 2371-2379.